NewEdge Advisors’s Cano Health, Inc. CANO Stock Holding History

NewEdge Advisors’s Portfolio CANO Stock Details CANO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-7	Closed	-$959	–	4288
2022 Q4	$959	Buy	+7	New	+$2.37K	﹤0.01%	3042

Other funds holding CANO

DCP

Diameter Capital Partners New York $1.07B AUM 152.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OCAM

Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return

NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

EHI

Eagle Health Investments Greenwich, Connecticut $572M AUM 67.49% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

NewEdge Advisors's CANO Position: Q1 2023 in Review

NewEdge Advisors sold out of Cano Health, Inc. (CANO) in Q1 2023, closing a stake of 7 shares — an estimated $959 sold.

NewEdge Advisors first reported a position in CANO in Q4 2022 and held it in 1 quarter. The position peaked at $959 in Q4 2022. 163 funds tracked by Wall St. Rank hold CANO as of Q1 2023.

NewEdge Advisors reported no remaining Cano Health, Inc. position as of Q1 2023 after selling out during the quarter.
NewEdge Advisors sold 7 Cano Health, Inc. shares in Q1 2023, an estimated $959.
NewEdge Advisors first reported a position in Cano Health, Inc. in Q4 2022 and held it in 1 quarter.
NewEdge Advisors's Cano Health, Inc. position peaked at $959 in Q4 2022.
163 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q1 2023.

Based on NewEdge Advisors's 13F filing for Q1 2023, filed 12 May 2023.